Endoscopic mucosal ablation and resection of Barrett's esophagus and related diseases

Journal of Visualized Surgery
Juan A Muñoz-Largacha, Virginia R Litle

Abstract

The prevalence of gastroesophageal reflux disease as well as the incidence of Barrett's esophagus (BE) has increased in the Western world over the last decades. The chronic reflux of gastric secretions injuries the esophageal mucosa and triggers cellular and molecular changes inducing the transformation of the normal squamous mucosa into columnar metaplastic epithelium. BE is a premalignant condition that can progress to low-grade dysplasia, high-grade dysplasia and ultimately esophageal adenocarcinoma. An early diagnosis of dysplastic changes and the adoption of appropriate therapeutic approaches are essential to improve patient outcomes and survival. Endoscopic therapies such as radiofrequency ablation (RFA) and endoscopic mucosal resection (EMR) have been developed to treat dysplastic changes and mucosal abnormalities suspicious of malignancy. RFA has shown to be safe and effective for the treatment of low and high-grade dysplasia. EMR is diagnostic for mucosal lesions and potentially therapeutic for high-grade dysplasia or intramucosal adenocarcinoma. Proficient endoscopic skills and frequent practice are essential elements for a successful result. Here, we describe patient selection, the pre- and post-operative management,...Continue Reading

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

Related Papers

Gastroenterology Research and Practice
Carmelo LuigianoBenedetto Mangiavillano
Journal of the National Comprehensive Cancer Network : JNCCN
Thomas B NealisRajesh N Keswani
Surgical Oncology Clinics of North America
Mariagnese Barbera, Rebecca C Fitzgerald
Current Opinion in Gastroenterology
Giovanni Zaninotto, Christian Rizzetto
© 2022 Meta ULC. All rights reserved